Rep. Wasserman Schultz Leads Bipartisan Push to Expand Medicare Coverage for Cancer Genetic Testing
This bill is sitting in the House Energy and Commerce and Ways and Means committees. It has not had any recorded action since July 2025, which means it has been stalled for about 11 months. Most bills like this do not receive a committee vote and do not move forward.
The bill has strong bipartisan support and focuses on saving lives through prevention, but the cost of expanding Medicare coverage can make it difficult to pass.
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 1526 (118th), which died when its Congress ended.
H.R. 1526 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Medicare would begin covering hereditary cancer genetic testing, risk-reducing preventive surgeries, and more frequent cancer screenings for beneficiaries with a family or personal history of hereditary cancer gene mutations. This expands access to potentially life-saving preventive care for an estimated 5-10% of Medicare beneficiaries who may have hereditary cancer risk, though the bill still needs to clear committee and both chambers of Congress.
“in the case of an individual with a personal or family history of a hereditary cancer gene mutation or a personal or family history suspicious for hereditary cancer, germline mutation testing”
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Rep. Debbie Wasserman Schultz is pushing for the Reducing Hereditary Cancer Act, introduced in July 2025, which would expand Medicare coverage for genetic testing to identify breast cancer risk in patients with a family history of the disease.
The legislative environment reflects powerful bipartisan support for measures like the Reducing Hereditary Cancer Act, which aims to expand early detection and genetic testing access for Medicare beneficiaries.
Senator Lisa Murkowski introduced the Reducing Hereditary Cancer Act (S. 2760) to expand Medicare coverage for genetic testing, screenings, and preventative care for individuals with a family history of hereditary cancer, aiming to catch the disease before it takes hold.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Reducing Hereditary Cancer Act
Analysis generated by AI. Always verify with official sources.